Endoplasmic Reticulum Stress Predicts Clinical Response to Cyclosporine Treatment in Primary Membranous Nephropathy

Publisher： Karger

E-ISSN： 1421-9670|43|5|348-356

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.43, Iss.5, 2016-05, pp. : 348-356

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Predictors of Response to Prednisone Plus Cyclophosphamide in Patients with Idiopathic Membranous Nephropathy

By  

Nephron, Vol. 135, Iss. 2, 2016-12 ,pp. : 87-96

Karger

Access to resources Recommend Favorite

A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)

By  

Nephron, Vol. 130, Iss. 3, 2015-06 ,pp. : 159-168

Karger

Access to resources Recommend Favorite

Serum Anti-PLA2R Antibody Predicts Treatment Outcome in Idiopathic Membranous Nephropathy

By  

American Journal of Nephrology, Vol. 43, Iss. 2, 2016-04 ,pp. : 129-140

Karger

Access to resources Recommend Favorite

Effective Treatment of Idiopathic Membranous Nephropathy

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 507-508

Karger

Access to resources Recommend Favorite

Rituximab Treatment for Membranous Nephropathy: A French Clinical and Serological Retrospective Study of 28 Patients

By  

Nephron Extra, Vol. 1, Iss. 1, 2011-12 ,pp. : 251-261

Karger

Access to resources Recommend Favorite